Vaccines in India are the ones which will be easiest to administer & transport. Most countries will benefit from it. India is known to produce in bulk quantities, once approved it can be rolled out quickly
We hope that with safety & efficacy data, Covaxin will be available in the first quarter of next year to the catego… https://t.co/EAnxbQ3jsB
— ANI (@ANI) 1607518304000